Exforge

Links shared publicly online about this topic

Exforge HCT approved for hypertension - MPR

empr.com — “The FDA has approved Novartis' Exforge HCT (amlodipine/valsartan/hydrochlorothiazide) tablets, a combination product containing a calcium channel blocker, an angiotensin receptor blocker, and a diuretic, for the treatment of hypertension.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on May 1, 2009 at 5:06 pm By:

eMPR MPR Medical Publisher

MPR News: Exforge HCT approved for hypertension: The FDA has approved Novartis' Exforge HCT (amlodipine.. http://tinyurl.com/cm3de7

3 years ago...

iGuard.org - Exforge Drug Interactions, Exforge Side Effects and Exforge Patient Reviews

iguard.org — “iGuard.org - Exforge Drug Interactions, Exforge Side Effects and Exforge Patient ReviewsView full resource at iguard.org

  • View Related
  • Share

Most Recently Shared on February 9, 2010 at 4:17 pm By:

MediGuard.org - Exforge | Drug safety information | Monitoring more than 1,400 patients

mediguard.org — “MediGuard.org - Exforge | Drug safety information | Monitoring more than 1,400 patientsView full resource at mediguard.org

  • View Related
  • Share

Most Recently Shared on March 9, 2011 at 2:17 am By:

FDA approves Exforge HCT - the only high blood pressure treatment to combine three medications in a single pill

novartis.com — “Basel, 30 April, 2009 - The US Food and Drug Administration (FDA) has approved Exforge HCT, the only single pill to combine the three most prescribed high blood pressure treatments in their classes in the US[3]: the calcium channel blocker amlodipine, the angiotensin receptor blocker valsartan, and the diuretic hydrochlorothiazide. Exforge HCT is an important new option for patients who have tried taking dual combinations of these classes of blood pressure medications without success.View full resource at novartis.com

  • View Related
  • Share

Most Recently Shared on April 30, 2009 at 8:57 pm By:

Novartis Novartis Pharma

FDA approves Exforge HCT® - the only high blood pressure treatment to combine three medications in a single pill: http://twurl.nl/rwohsw

3 years ago...

Novartis receives approval in the European Union for Exforge HCT, a new 3-in-1 treatment for high blood pressure

novartis.com — “DisclaimerView full resource at novartis.com

  • View Related
  • Share

Most Recently Shared on October 23, 2009 at 5:39 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

Novartis receives approval in the EU for Exforge HCT®, a new 3-in-1 treatment for high blood pressure http://bit.ly/PmGkX

3 years ago...

Three-drug combo for hypertension

theheart.org — “Latest advances and developments in Hypertension from heartwire news, renowned specialists and the American Society of Hypertension (ASH).View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on May 1, 2009 at 9:32 pm By:

theheartorg Shelley Wood Cardiology

heartwire: Combination diuretic, ARB, and CCB approved for treatment of hypertension http://bit.ly/177kYv

3 years ago...

Triple approval for Novartis in Japan | InPharm

inpharm.com — “Triple approval for Novartis in Japan | InPharmView full resource at inpharm.com

  • View Related
  • Share

Most Recently Shared on January 20, 2010 at 12:50 pm By:

Pharmafocus Pharmafocus Health News and Pharma

Triple approval for Novartis in Japan. Regulators pass Equa (Galvus in Europe), Exforge and Afinitor. http://ow.ly/Yxib

2 years ago...

Three-Drug Combo for Hypertension

urlborg.com — “: The US Food and Drug Administration this week approved an antihypertensive medication that combines hydrochlorothiazide with valsartan, an angiotensin receptor blocker (ARB), and amlodipine, a calcium-channel blocker (CCB) (Exforge HCT, Novartis).View full resource at urlborg.com

  • View Related
  • Share

Most Recently Shared on May 1, 2009 at 10:43 pm By:

medscapenurses Medscape Nurses Nursing

Combination Diuretic, ARB, and CCB Approved for Treatment of Hypertensio: The US Food and Drug Administration th.. http://ub0.cc/85/0H

3 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • eMPR

    MPR

    eMPR.com provides up-to-date, concise drug information at the point-of-care.

    View Profile

  • MediGuard

    MediGuard.org

    Live health insights from 2.5+ million users of MediGuard, the easiest way to get safety alerts and recalls for your medicines.

    View Profile

  • MediGuard

    MediGuard.org

    Live health insights from 2.5+ million users of MediGuard, the easiest way to get safety alerts and recalls for your medicines.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390